2BBBullish & Bearish
Pliant Therapeutics, Inc. (PLRX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 52 out of 100.
Pliant Therapeutics, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 58 | Moderate |
| Momentum | 76 | Improving |
| Financial strength | 16 | Very Weak |
| Quality | 60 | Strong |
| Risk | 37 | Low |
| Founded | 2015 |
| Employees | 49 |
| 52-week range | $1.02 – $1.95 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.3876 | — | $0.00 |
| 2026-08-10 | — | -0.3488 | — | $0.00 |
| 2026-05-11 | -0.32 | -0.3638 | $0.00 | $0.00 |
| 2026-03-11 | -0.38 | -0.3856 | $0.00 | $0.00 |